α-Melanocyte-stimulating hormone inhibits NF-κB activation and IκBα degradation in human glioma cells and in experimental brain inflammation

Experimental Neurology

Volumn 157, Issue 2, 1999, Pages 359-365

  Ichiyama, Takashi ^a,c   Zhao, Hui ^a   Catania, Anna ^b   Furukawa, Susumu ^c   Lipton, James M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Astrocyte; Inflammation; Lipopolysaccharide; NF B; I B ; Melanocyte stimulating hormone

Indexed keywords

ALPHA INTERMEDIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; MELANOCORTIN RECEPTOR;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ENCEPHALITIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLIA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0033050644     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7064     Document Type: Article

References (51)

1. Baeuerle P. A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
2. Baldwin A. S. Jr. The NF-κB and IκB proteins: New discoveries and insights. Annu. Rev. Immunol. 14:1996;649-683.
3. Becker K. J. Inflammation and acute stroke. Curr. Opin. Neurol. 11:1998;45-49.
4. Brach M. A., de Vos S., Arnold C., Gruß H. J., Mertelsmann R., Herrmann F. Leukotriene B4 transcriptionally activates interleukin-6 expression involving NF-κB and NF-IL6. Eur. J. Immunol. 22:1992;2705-2711.
5. Brown K., Gerstberger S., Carlson L., Franzoso G., Siebenlist U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science. 267:1995;1485-1488.
6. Carlson S. L., Parrish M. E., Springer J. E., Ketah D., Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp. Neurol. 151:1998;77-88.
7. Catania A., Lipton J. M. α-Melanocyte stimulating hormone in the modulation of host reactions. Endocr. Rev. 14:1993;564-576.
8. Catania A., Lipton J. M. α-Melanocyte-stimulating hormone peptides in host responses: From basic evidence to human research. Ann. N. Y. Acad. Sci. 680:1993;412-423.
9. Chen C. C., Rosenbloom C. L., Anderson D. C., Manning A. M. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of IκB-α phosphorylation. J. Immunol. 155:1995;3538-3545.
10. Collart M. A., Baeuerle P., Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1990;1498-1506.
11. Delgado R., Carlin A., Airaghi L., Demitri M. T., Meda L., Galimberti D., Baron P., Lipton J. M., Catania A. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J. Leukocyte Biol. 63:1998;740-745.
12. Delude R. L., Fenton M. J., Savedra R. Jr., Perera P. Y., Vogel S. N., Thieringer R., Golenbock D. T. CD14-mediated translocation of nuclear factor-κB induced by lipopolysaccharide does not require tyrosine kinase activity. J. Biol. Chem. 269:1994;22253-22260.
13. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
14. Eustice D. C., Feldman P. A., Colberg-Poly A. M., Buckery R. M., Neubauer R. H. A sensitive method for the detection of β-galactosidase in transfected mammalian cells. Biotechniques. 11:1991;739-742.
15. Fassbender K., Rossol S., Kammer T., Daffertshofer M., Wirth S., Dollman M., Hennerici M. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: Kinetics of secretion and relation to the extent of brain damage and outcome of disease. J. Neurol. Sci. 122:1994;135-139.
16. Grimm S., Baeurle P. A. The inducible transcription factor NF-κB: Structure-function relationship of its protein subunits. Biochem. J. 290:1993;297-308.
17. Haley T. J., McCormick W. G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
18. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J. D., Wenk G. L. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 780:1998;294-303.
19. Henkel T., Machleidt T., Alkalay I., Krönke M., Ben-Neriah Y., Baeuerle P. A. Rapid proteolysis of IκB-α is necessary for activation of transcriptional factor NF-κB. Nature. 365:1993;182-185.
20. Hiltz M. E., Catania A., Lipton J. M. α-MSH peptides inhibit acute inflammation induced in mice by rIL-1β, rIL-6, rTNF-α and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8. Cytokine. 4:1992;320-328.
21. Hiscott J., Marois J., Garoufalis J., D'Addario M., Roulston A., Kwan I., Pepin N., Lacoste J., Nguyen H., Bensi G., Fenton M. Characterization of a functional NF-κB site in the human interleukin 1β promotor: Evidence for a positive autoregulatory loop. Mol. Cell. Biol. 13:1993;6231-6240.
22. Kumar A., Haque J., Lacoste J., Hiscott J., Williams B. R. G. Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proc. Natl. Acad. Sci. USA. 91:1994;6288-6292.
23. Kunsch C., Lang R. K., Rosen C. A., Shannon M. F. Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6. J. Immunol. 153:1994;153-164.
24. Lentsch A. B., Shanley T. P., Sarma V., Ward P. A. In vivo suppression of NF-κB and preservation of IκBα by interleukin-10 and interleukin-13. J. Clin. Invest. 100:1997;2443-2448.
25. Libermann T. A., Baltimore D. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell. Biol. 10:1990;2327-2334.
26. Lipton J. M., Macaluso A., Hiltz M. E., Catania A. Central administration of the peptide α-MSH inhibits inflammation in the skin. Peptides. 12:1991;795-798.
27. Lipton J. M., Catania A. Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunol. Today. 18:1997;140-145.
28. Lipton J. M., Catania A. Mechanisms of antiinflammatory action of the neuroimmunomodulatory peptide α-MSH. Ann. N. Y. Acad. Sci. 840:1998;373-380.
29. Liu J., Marino M. W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A. J., Old L., Bernard C. C. A. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4:1998;78-83.
30. Liu T., Clark R. K., McDonnell P. C., Young P. R., White R. F., Barone F. C., Feuerstein G. Z. Tumor necrosis factor-α expression in ischemic neurons. Stroke. 25:1994;1481-1488.
31. Mackenzie I. R. A., Munoz D. G. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology. 50:1998;986-990.
32. Manna S. K., Aggarwal B. B. α-Melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-κB activation induced by various inflammatory agents. J. Immunol. 161:1998;2873-2880.
33. Matsusaka T., Fujikawa K., Nishio Y., Mukaida N., Matsushima K., Kishimoto T., Akira S. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. USA. 90:1993;10193-10197.
34. McGeer P. L., McGeer E. G. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:1995;195-218.
35. Navikas V., Link H. Cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45:1996;322-333.
36. Ollivier V., Parry G. C. N., Cobb R. R., de Prost D., Mackman N. Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J. Biol. Chem. 271:1996;20828-20835.
37. O'Neill L. A. J., Kaltschmidt C. NF-κB: A crucial transcription factor for glial and neuronal function. Trends Neurosci. 20:1997;252-258.
38. Rajora N., Ceriani G., Catania A., Star R. A., Murphy M. T., Lipton J. M. α-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J. Leukocyte Biol. 59:1996;248-253.
39. Rajora N., Boccoli G., Burns D., Sharma S., Catania A. P., Lipton J. M. α-MSH modulates local and circulating tumor necrosis factor-α in experimental brain inflammation. J. Neurosci. 17:1997;2181-2186.
40. Roulston A., Lin R., Beauparlant P., Wainberg M. A., Hiscott J. Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-κB/Rel transcription factors. Microbiol. Rev. 59:1995;481-505.
41. Schreiber E., Matthias P., Müller M. M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
42. Seeler J. S., Muchardt C., Podar M., Gaynor R. B. Regulatory elements involved in Tax-mediated transactivation of the HTLV-1 LTR. Virology. 196:1993;442-450.
43. Star R. A., Rajora N., Huang J., Stock R. C., Catania A., Lipton J. M. Evidence of autocrine modulation of macrophage nitric oxide synthase by α-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. USA. 92:1995;8016-8020.
44. Tatro J. B., Reichlin S. Specific receptors for α-melanocyte-stimulating hormone are widely distributed in tissues of rodents. Endocrinology. 121:1987;1900-1907.
45. Tatro J. B. Brain receptors for central and peripheral melanotropins. Ann. N. Y. Acad. Sci. 680:1993;621-625.
46. Taupin V., Toulmond S., Serrano A., Benavides J., Zavala F. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. J. Neuroimmunol. 42:1993;177-186.
47. Ueda A., Ishigatsubo Y., Okubo T., Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. J. Biol. Chem. 272:1997;31092-31099.
48. Weidenfeld J., Crumeyrolle-Arias M., Haour F. Effect of bacterial endotoxin and interleukin-1 on prostaglandin biosynthesis by the hippocampus of mouse brain: Role of interleukin-1 receptors and glucocorticoids. Neuroendocrinology. 62:1995;39-46.
49. Weiss J. M., Sundar S. K., Cierpial M. A., Ritchie J. C. Effects of interleukin-1 infused into brain are antagonized by α-MSH in a dose-dependent manner. Eur. J. Pharmacol. 192:1991;177-179.
50. Wong K. Y., Rajora N., Boccoli G., Catania A., Lipton J. M. A potential mechanism of local anti-inflammatory action of alpha-melanocyte-stimulating hormone within the brain: Modulation of tumor necrosis factor-alpha production by human astrocytic cells. Neuroimmunomodulation. 4:1997;37-41.
51. Yamasaki Y., Suzuki T., Yamaya H., Matsuura N., Onodera H., Kogure K. Possible involvement of interleukin-1 in ischemic brain edema formation. Neurosci. Lett. 142:1992;45-47.